Dr. Naomi Scarano obtained a Master's Degree in Chemistry at the University of Turin in 2021, with a computer-aided drug design thesis regarding the mechanism of action of full and partial agonists of the Peroxisome Proliferator-Activated Receptor gamma. She continued her studies at the University of Genoa, obtaining a PhD in Computational Medicinal Chemistry. During this period, she applied computational techniques to investigate non-classical targets associated with neurodegenerative disorders, with a particular focus on Alzheimer's disease. In the context of her doctoral studies, she collaborated with renowned research centers in Italy and abroad. Currently, she is employed as a computational chemist at the CNR-ITB, where she investigates the effect of point mutations on protein structures in an attempt to target pathogenic mutants. Her interests also include GPCRs, Intrinsically Disordered Proteins, and PROTACs.